Literature DB >> 3923920

Selective inhibition of the accumulation of extracellular proteases of Pseudomonas aeruginosa by gentamicin and tobramycin.

R L Warren, N R Baker, J Johnson, M J Stapleton.   

Abstract

Gentamicin and tobramycin inhibited the accumulation of extracellular proteases secreted by Pseudomonas aeruginosa. The secretion of protease was inhibited at concentrations of these drugs that were below the level required to inhibit general protein synthesis. Neither magnesium ions nor high ionic strength antagonized the ability of the aminoglycosides to block secretion of the proteases. Under these culture conditions magnesium ions were shown to antagonize the effects of the aminoglycosides on protein synthesis and aminoglycoside-mediated lysozyme lysis of P. aeruginosa. These results suggested that the drugs blocked secretion of the proteases by acting at the level of the outer membrane.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3923920      PMCID: PMC180076          DOI: 10.1128/AAC.27.4.468

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

Review 1.  Opportunistic infection in children. II. In the compromised host.

Authors:  R D Feigin; W T Shearer
Journal:  J Pediatr       Date:  1975-11       Impact factor: 4.406

2.  Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin.

Authors:  T I Nicas; R E Hancock
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

3.  Demonstration of a cell-associated, inactive precursor of an exocellular protease produced by Pseudomonas aeruginosa.

Authors:  S E Jensen; I T Fecycz; G W Stemke; J N Campbell
Journal:  Can J Microbiol       Date:  1980-01       Impact factor: 2.419

4.  Enzyme immunoassay ELISA and EMIT.

Authors:  E Engvall
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Microscopic characterization of rabbit lung damage produced by Pseudomonas aeruginosa proteases.

Authors:  L Gray; A Kreger
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

6.  Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor.

Authors:  K Morihara; H Tsuzuki; K Oda
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  Assessment of protease (elastase) as a Pseudomonas aeruginosa virulence factor in experimental mouse burn infection.

Authors:  O R Pavlovskis; B Wretlind
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

8.  Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa.

Authors:  R E Hancock; V J Raffle; T I Nicas
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

9.  Role of ionic strength in salt antagonism of aminoglycoside action on Escherichia coli and Pseudomonas aeruginosa.

Authors:  W H Beggs; F A Andrews
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

Review 10.  Aminoglycoside uptake and mode of action-with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells.

Authors:  R E Hancock
Journal:  J Antimicrob Chemother       Date:  1981-12       Impact factor: 5.790

View more
  11 in total

1.  Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice.

Authors:  Y Hirakata; M Kaku; K Tomono; K Tateda; N Furuya; T Matsumoto; R Araki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  Hydrophobicity and outer membrane proteins of Shigella dysenteriae type 1 after treatment with subinhibitory concentrations of aminoglycosides.

Authors:  A Hostacká; E Karelová
Journal:  Folia Microbiol (Praha)       Date:  1997       Impact factor: 2.099

3.  Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients.

Authors:  M Trancassini; D de Vito; G Cimino; M Antonelli; S Quattrucci; P Cipriani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

4.  Tn5-induced protease-deficient strains of Aeromonas hydrophila with reduced virulence for fish.

Authors:  K Y Leung; R M Stevenson
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Antimicrobial efficacy of quaternary bisammonium salts and the effect of their sub-MICs on Pseudomonas aeruginosa virulence factors.

Authors:  A Hostacká; V Majtán; D Hybenová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

6.  Effects of FP2 and a mercury resistance plasmid from Pseudomonas aeruginosa PA103 on exoenzyme production.

Authors:  J Johnson; R L Warren; A A Branstrom
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

7.  Enzymic and permeability activity of Pseudomonas aeruginosa after treatment with sub-MICs of organic ammonium salts.

Authors:  A Hostacká; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

8.  Effects of subinhibitory concentrations of antibiotics on biological properties of Salmonella typhimurium.

Authors:  L Majtánová; A Hostacká; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

9.  Alterations in Pseudomonas aeruginosa exoproducts by sub-MICs of some antibiotics.

Authors:  A Hostacká; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1993       Impact factor: 2.099

10.  Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa.

Authors:  Y Hirakata; M Kaku; R Mizukane; K Ishida; N Furuya; T Matsumoto; K Tateda; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.